Who Paid My Doc
William Smith
New Orleans, LA Medical Doctor
NPI 1124024054 CMS profile 1309787
2820 Canal St, Fl 1, New Orleans, LA 70119
General payments
$9,570
Research payments
$138,331
Ownership & investment interest
$0
Research they led as principal investigator
$50,446,961
Through program year 2025, William Smith of New Orleans, LA is reported in the CMS Open Payments database as having received $9,570 across 38 general payments and $138,331 in research payments paid to them. Separately, studies naming them as principal investigator received $50,446,961 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
By program year
12 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $37 | 1 | |
| 2024 | General | $682 | 8 | |
| 2024 | Research | $3,200 | 1 | |
| 2023 | General | $1,082 | 8 | |
| 2023 | Research | $2,130 | 12 | |
| 2022 | General | $21 | 1 | |
| 2022 | Research | $131,663 | 12 | |
| 2021 | General | $20 | 1 | |
| 2021 | Research | $1,138 | 1 | |
| 2020 | General | $17 | 1 | |
| 2020 | Research | $200 | 1 | |
| 2019 | General | $7,711 | 18 |
Beside peers
- William Smith
- Louisiana median
- Middle half of Louisiana
- National median
In program year 2025, general payments to William Smith were reported at $37. Among 17,571 Louisiana profiles paid that year, the median was $214 and the middle half received between $59 and $703.
Show as a table
| Year | William Smith | Louisiana median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $7,711 | $195 | $58–$685 | $163 |
| 2020 | $17 | $131 | $39–$424 | $114 |
| 2021 | $20 | $152 | $41–$539 | $132 |
| 2022 | $21 | $179 | $51–$616 | $149 |
| 2023 | $1,082 | $201 | $57–$673 | $160 |
| 2024 | $682 | $197 | $56–$676 | $164 |
| 2025 | $37 | $214 | $59–$703 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 5 billing codesPaid by Medicare
$1,591
Medicare patients
16
Services billed
21
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
65 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.